IP Verse

Effective Generation Of Tumor-Targeted T-Cells Derived From Pluripotent Stem Cells

Patent No. EP2981607 (titled "Effective Generation Of Tumor-Targeted T-Cells Derived From Pluripotent Stem Cells") was filed by Memorial Sloan Kettering Cancer Center on Apr 3, 2014. The application was issued on Aug 19, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBMay 19, 2021VOSSIUS & PARTNER
VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBMay 19, 2021VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
STRAWMANMar 31, 2021CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2981607

MEMORIAL SLOAN KETTERING CANCER CENTER
Application Number
EP14722926A
Filing Date
Apr 3, 2014
Status
Revoked
Sep 27, 2024
Publication Date
Aug 19, 2020
External Links
Slate, Register , Google Patents